Arkopharma Names Christophe Mossé as its New CEO
Founded in 1980 in Carros, Arkopharma specializes in phytotherapy, natural medicines, and dietary supplements. Recently, the European leader in this field announced Christophe Mossé as its new CEO.
Christophe Mossé, with extensive experience in the pharmaceutical sector both in France and globally, is set to lead Arkopharma and oversee the operations of Dermapharm Group. He will serve as the primary liaison between the management teams of both organizations.
Arkopharma, now operating in over 60 countries, stands as a European leader in phytotherapy medicines and dietary supplements. With a workforce of 1,212 employees and a consolidated revenue of 201 million euros, the company allocates 8.5% of its personnel to research and development. Arkopharma boasts 1,635 registrations and marketing authorizations for its products.
Have you read?
Fastest tanks ever built by Russia.
Impact of Titles on Your Executive Career – Negotiating Job Titles and more!
3 Ways Technology Empowers the Hybrid Work Revolution.
5 Effective Strategies to Reduce Criticism and Captivate Your Essay Readers.
CerebrumIQ Reviews the Average IQ for Managers and Executives.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz